Legislation Seeks to Overhaul FDA's Compassionate Use Program
By Alexander Gaffney, RAC -
Published 09 December 2014
New legislation introduced in the House of Representatives would makes changes to the US Food and Drug Administration's (FDA) "expanded access"—sometimes called "compassionate use"—policies in the hopes of making it easier for terminally ill patients to access potentially life-saving drugs.
Categories: News, US, CDER, Biologics and biotechnology, Clinical, Drugs
Tags: Compassionate Use, Expanded Access, Legislation, Bill, House, Andrea Sloan